Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naval Daver

Showing results (61-70 of 435) with videos related to

Pageof 44
Sort By:
Annals of Hematology|March 31, 2021
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cellsZhihong Zeng, Charlie Ly, Naval Daver, et al.
Frontiers in Oncology|June 12, 2014
Extramedullary acute myeloid leukemia: leukemic pleural effusion, case report and review of the literatureNaveen Pemmaraju, Elaine Chang, Naval Daver, et al.
Leukemia|March 1, 2018
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromesNaval Daver, Prajwal Boddu, Guillermo Garcia-Manero, et al.
Journal of Medical Case Reports|June 28, 2017
Adult cancer-related hemophagocytic lymphohistiocytosis - a challenging diagnosis: a case reportMichael A Hust, Boris R A Blechacz, Diana L Bonilla, et al.
Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.
Haematologica|May 19, 2018
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in <i>FLT3</i>-mutated acute myeloid leukemias: from concept to clinical trialWeiguo Zhang, Charlie Ly, Jo Ishizawa, et al.
Blood|March 22, 2015
Secondary mutations as mediators of resistance to targeted therapy in leukemiaNaval Daver, Jorge Cortes, Farhad Ravandi, et al.
Cancer Discovery|February 5, 2020
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New ChallengesNicholas J Short, Marina Konopleva, Tapan M Kadia, et al.
Leukemia & Lymphoma|September 30, 2017
PET-CT in AML-related hemophagocytic lymphohistiocytosisPrajwal Boddu, Sergio Pina Oviedo, Caitlin R Rausch, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 5, 2014
Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challengePraveen Ramakrishnan Geethakumari, Marc S Hoffmann, Naveen Pemmaraju, et al.
Pageof 44

Showing results (61-70 of 435) with videos related to

Sort By:
Pageof 44
Annals of Hematology|March 31, 2021
High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cellsZhihong Zeng, Charlie Ly, Naval Daver, et al.
Frontiers in Oncology|June 12, 2014
Extramedullary acute myeloid leukemia: leukemic pleural effusion, case report and review of the literatureNaveen Pemmaraju, Elaine Chang, Naval Daver, et al.
Leukemia|March 1, 2018
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromesNaval Daver, Prajwal Boddu, Guillermo Garcia-Manero, et al.
Journal of Medical Case Reports|June 28, 2017
Adult cancer-related hemophagocytic lymphohistiocytosis - a challenging diagnosis: a case reportMichael A Hust, Boris R A Blechacz, Diana L Bonilla, et al.
Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.
Haematologica|May 19, 2018
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in <i>FLT3</i>-mutated acute myeloid leukemias: from concept to clinical trialWeiguo Zhang, Charlie Ly, Jo Ishizawa, et al.
Blood|March 22, 2015
Secondary mutations as mediators of resistance to targeted therapy in leukemiaNaval Daver, Jorge Cortes, Farhad Ravandi, et al.
Cancer Discovery|February 5, 2020
Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New ChallengesNicholas J Short, Marina Konopleva, Tapan M Kadia, et al.
Leukemia & Lymphoma|September 30, 2017
PET-CT in AML-related hemophagocytic lymphohistiocytosisPrajwal Boddu, Sergio Pina Oviedo, Caitlin R Rausch, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 5, 2014
Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challengePraveen Ramakrishnan Geethakumari, Marc S Hoffmann, Naveen Pemmaraju, et al.
Pageof 44